Literature DB >> 18287805

The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients.

Fulya Akin1, Guzin Fidan Yaylali, Mehmet Bastemir.   

Abstract

OBJECTIVE: The aim of this study was to elucidate the effectiveness of lithium carbonate prior to thyroidectomy or radioiodide therapy in patients with thyrotoxicosis. SUBJECTS AND METHODS: Lithium carbonate was used as preoperative preparation or radioiodide therapy in 5 patients with Graves' disease and in 1 patient with toxic multinodular goiter because of side effects of thionamide in 5 patients and ineffectiveness of antithyroid medication in the remaining patient.
RESULTS: All 6 patients had a benign course following treatment without thyroid storm. No adverse effects or complications of lithium carbonate were observed.
CONCLUSION: This report shows that lithium carbonate can be safely used preoperatively or prior to radioiodide therapy in circumstances where antithyroid medications are contraindicated and are ineffective in obtaining an euthyroid status. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287805     DOI: 10.1159/000112975

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  5 in total

1.  Contrast induced hyperthyroidism due to iodine excess.

Authors:  Usman Mushtaq; Timothy Price; Narsing Laddipeerla; Amanda Townsend; Vy Broadbridge
Journal:  BMJ Case Rep       Date:  2009-11-04

2.  Resistant thyrotoxicosis in a patient with graves disease: a case report.

Authors:  Taimur Saleem; Aisha Sheikh; Qamar Masood
Journal:  J Thyroid Res       Date:  2011-08-10

3.  Preoperative Preparation of Hyperthyroidism for Thyroidectomy - Role of Supersaturated Iodine and Lithium Carbonate.

Authors:  Gopalakrishnan C Nair; Misha J C Babu; Riju Menon; Pradeep Jacob
Journal:  Indian J Endocrinol Metab       Date:  2018 May-Jun

Review 4.  Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.

Authors:  Yusaku Mori; Munenori Hiromura; Michishige Terasaki; Hideki Kushima; Makoto Ohara; Tomoyasu Fukui; Yasuyoshi Takahashi; Sho-Ichi Yamagishi
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Lithium Carbonate in the Treatment of Graves' Disease with ATD-Induced Hepatic Injury or Leukopenia.

Authors:  Rendong Zheng; Kemian Liu; Kun Chen; Wen Cao; Lin Cao; Huifeng Zhang; Hongping Sun; Chao Liu
Journal:  Int J Endocrinol       Date:  2015-10-20       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.